ResearcherSecond Military Medical UniversityActive in the last 2 years

Di Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2186-7717; OpenAlex author ID A5100368455, A5130035490. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

AURKA promotes radioresistance in pancreatic cancer via GSK3β-mediated PTEN phosphorylation at T366. Co-author DOI 10.1016/j.yexcr.2026.114986 ↗
Regulation of pancreatic cancer microenvironment by an intelligent gemcitabine@nanogel system via in vitro 3D model for promoting therapeutic efficiency. Co-author DOI 10.1016/j.jconrel.2020.06.001 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Huojun Zhang · 2 shared papers, 2020–2026 · strength 0.39
- Paper AURKA promotes radioresistance in pancreatic cancer via GSK3β-mediated PTEN phosphorylation at T366. DOI 10.1016/j.yexcr.2026.114986 ↗
- Paper Regulation of pancreatic cancer microenvironment by an intelligent gemcitabine@nanogel system via in vitro 3D model for… DOI 10.1016/j.jconrel.2020.06.001 ↗
Wei Li · 1 shared paper, 2020 · strength 0.09
- Paper Regulation of pancreatic cancer microenvironment by an intelligent gemcitabine@nanogel system via in vitro 3D model for… DOI 10.1016/j.jconrel.2020.06.001 ↗
Lingong Jiang · 1 shared paper, 2020 · strength 0.09
- Paper Regulation of pancreatic cancer microenvironment by an intelligent gemcitabine@nanogel system via in vitro 3D model for… DOI 10.1016/j.jconrel.2020.06.001 ↗
Xiaofei Zhu · 1 shared paper, 2020 · strength 0.09
- Paper Regulation of pancreatic cancer microenvironment by an intelligent gemcitabine@nanogel system via in vitro 3D model for… DOI 10.1016/j.jconrel.2020.06.001 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.